Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;107(2):222-224.
doi: 10.1136/archdischild-2021-321611. Epub 2021 Jun 3.

Catheter insertion depths in less-invasive surfactant administration

Affiliations

Catheter insertion depths in less-invasive surfactant administration

Christian Achim Maiwald et al. Arch Dis Child Fetal Neonatal Ed. 2022 Mar.

Abstract

Introduction: Less-invasive surfactant administration (LISA) under continuous positive airway pressure is increasingly used for the treatment of neonatal respiratory distress. Different procedures are described, but data on the optimal catheter insertion depth are sparse.

Objective: To generate data for recommending an optimal catheter insertion depth in LISA.

Methods: We examined 112 anterior-posterior chest X-rays from intubated infants and determined the carina's vertebral projection, whenever possible. After that, distances between the middle of cervical vertebra 4 (C4) and thoracic vertebra 2 and the middle of C4 to thoracic vertebra 3, respectively, were measured. Results were plotted against infant's weight.

Results: A weight-based chart and recommendations for the optimal intratracheal catheter position in infants with a body weight between 350 and 4000 g were created.

Conclusions: Generated data offer standardisation and may thus help to find a balance between risk of surfactant reflux and unilateral surfactant administration.

Keywords: neonatology; therapeutics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CAM has a financial relationship in the profits of the Neofact product as inventor and his research projects are partially supported by Lyomark Pharma. The other authors have indicated they have no conflicts of interest relevant to this article to disclose.

MeSH terms

Substances

LinkOut - more resources